[Preliminary results with antimetabolite therapy of autoaggressive diseases in dermatology].
D000963:Antimetabolites / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003348:Cortisone / Q000627:therapeutic use; D003882:Dermatomyositis / Q000188:drug therapy; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D015122:Mercaptopurine / Q000627:therapeutic use*; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D000963:Antimetabolites; D015122:Mercaptopurine; D003348:Cortisone
Vorläufige Erfahrungen mit Antimetaboliten-Therapie von Autoaggressionskrankheiten in der Dermatologie.